Abstract
In study one, 163 adults with intellectual disabilities (ID) who chronically received psychotropic medications were evaluated to further establish psychometric properties of the Matson Evaluation of Drug Side-effects (MEDS). Test–retest reliability was also examined for 76 adults. Cutoff scores for total and subfactors are reported as well as the implications of the present data for evaluating antipsychotic medications. In study two of our paper, we explored drug prescription practices for the same 163 participants. While most participants had been switched to atypical antipsychotic drugs, akathisia and tardive dyskinesia were still typical and frequent side effects. The implication of the data in these studies is discussed with respect to using the MEDS as a means of assessing side effects resulting from chronic antipsychotic drug use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Developmental and Physical Disabilities
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
